Algert Global LLC Has $8.46 Million Position in Doximity, Inc. (NASDAQ:DOCS)

Algert Global LLC raised its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 71.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 158,367 shares of the company's stock after purchasing an additional 65,922 shares during the quarter. Algert Global LLC owned 0.08% of Doximity worth $8,455,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. FMR LLC boosted its stake in shares of Doximity by 37.6% in the fourth quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after buying an additional 2,571,580 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Doximity by 708.7% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock valued at $80,641,000 after acquiring an additional 1,323,634 shares during the period. Invesco Ltd. boosted its stake in shares of Doximity by 525.1% during the 4th quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock worth $67,934,000 after acquiring an additional 1,068,849 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Doximity by 1,178.3% during the 4th quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after acquiring an additional 979,113 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Doximity by 4.5% in the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock worth $598,159,000 after acquiring an additional 485,102 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DOCS has been the topic of a number of research analyst reports. Needham & Company LLC boosted their target price on Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and raised their target price for the company from $60.00 to $90.00 in a report on Friday, February 7th. Leerink Partnrs raised shares of Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. Truist Financial decreased their target price on shares of Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Finally, Raymond James reissued an "outperform" rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $65.39.

Insider Activity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the sale, the director now owns 16,618 shares of the company's stock, valued at approximately $946,062.74. This trade represents a 10.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares in the company, valued at $20,440,552.95. This trade represents a 11.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by insiders.

Doximity Stock Down 0.4 %

Shares of DOCS stock traded down $0.25 during trading on Friday, reaching $59.10. The company's stock had a trading volume of 1,770,373 shares, compared to its average volume of 2,011,334. The business has a fifty day moving average price of $58.16 and a 200-day moving average price of $57.03. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21. The company has a market cap of $11.03 billion, a price-to-earnings ratio of 59.10, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.